Miss Gill Cann
- Affiliate (School of Chemistry)
email:
Gillian.Cann@gla.systa-s.com
Keltic Pharma Therapeutics, The ARC, University of Glasgow, Glasgow, G11 6EW
Publications
2025
Brettell, Skye B., Cann, Gillian, Begen, Abbey, Sharma, Saumya, Mahindra, Amit, Carruthers, Lauren V. 
ORCID: https://orcid.org/0000-0003-4346-2283, Milligan, Graeme ORCID: https://orcid.org/0000-0002-6946-3519, Clarke, David J., Tobin, Andrew B. ORCID: https://orcid.org/0000-0002-1807-3123 and Jamieson, Andrew G. ORCID: https://orcid.org/0000-0003-1726-7353
(2025)
Lysine targeting covalent inhibitors of malarial kinase PfCLK3.
RSC Medicinal Chemistry, 16(8),
pp. 3530-3540.
(doi: 10.1039/d5md00335k)
(PMID:40521344)
(PMCID:PMC12164071)
Articles
Brettell, Skye B., Cann, Gillian, Begen, Abbey, Sharma, Saumya, Mahindra, Amit, Carruthers, Lauren V. ORCID: https://orcid.org/0000-0003-4346-2283, Milligan, Graeme ORCID: https://orcid.org/0000-0002-6946-3519, Clarke, David J., Tobin, Andrew B. ORCID: https://orcid.org/0000-0002-1807-3123 and Jamieson, Andrew G. ORCID: https://orcid.org/0000-0003-1726-7353
(2025)
Lysine targeting covalent inhibitors of malarial kinase PfCLK3.
RSC Medicinal Chemistry, 16(8),
pp. 3530-3540.
(doi: 10.1039/d5md00335k)
(PMID:40521344)
(PMCID:PMC12164071)